BCRX icon

BioCryst Pharmaceuticals
BCRX

Overview Fund Activity

134 hedge funds and large institutions have $245M invested in BioCryst Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 52 increasing their positions, 38 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
134
Holders Change
-2
Holders Change %
-1.47%
% of All Funds
2.96%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
26
Increased
52
Reduced
38
Closed
25
Calls
$3.05M
Puts
$396K
Net Calls
+$2.66M
Net Calls Change
+$1.39M

Top Buyers

1
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
$15M
2
Balyasny Asset Management
2
Balyasny Asset Management
Illinois
$6.01M
3
EP
3
Eversept Partners
New York
$15.1M
4
Stifel Financial
4
Stifel Financial
Missouri
$4.18M
5
Fidelity Investments
5
Fidelity Investments
Massachusetts
$5.11M

Top Sellers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$6.04M
2
Janus Henderson Group
2
Janus Henderson Group
United Kingdom
$9.76M
3
PVI
3
Pura Vida Investments
New York
$0
4
Millennium Management
4
Millennium Management
New York
$12.9M
5
ACP
5
Acuta Capital Partners
California
$500K
Name Holding Trade Value Shares
Change 		Shares
Change %
GTCM
151
Gyon Technologies Capital Management
New Jersey
– -$41K -11,851 Closed
PRC
152
Pearl River Capital
Michigan
– -$38K -10,989 Closed
QT
153
Quantamental Technologies
New York
– -$38K -10,989 Closed
Group One Trading
154
Group One Trading
Illinois
– -$19K -5,558 Closed
Simplex Trading
155
Simplex Trading
Illinois
– -$10K -2,903 Closed
1832 Asset Management
156
1832 Asset Management
Ontario, Canada
– -$7K -1,978 Closed
3 4 5 6
7